Suchergebnisse - "Otero, Jorge"

PubPharm (5)

1

Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) : Results of an Observational Longitudinal Cohort Study

enthalten in: Targeted oncology | 2023

von Chamorro, D. | Cardona, A. | Rodríguez, J. | +35

2

Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP)

enthalten in: Clinical lung cancer | 2022

von Cardona, A. | Ruiz-Patiño, A. | Recondo, G. | +36

3

Real-World Treatment Patterns, Survival, and Prediction of CNS Progression in ALK-Positive Non-Small-Cell Lung Cancer Patients Treated with First-Line Crizotinib in Latin America Oncology Practices

enthalten in: Oncology | 2018

von Martín, C. | Cardona, A. | Zatarain-Barrón, Z. | +16

4

Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America : The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2015

von Arrieta, O. | Cardona, A. | Martín, C. | +17

5

The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2015

von Arrieta, O. | Cardona, A. | Corrales, L. | +91

1
[1]